See What HealthDay Can Do For You
Contact Us

In-Hospital Mortality Down With Video-Assisted Thoracoscopic Sx

Shorter length of hospital stay, and lower likelihood of any perioperative morbidity with VATS

lungs

WEDNESDAY, Nov. 2, 2016 (HealthDay News) -- Video-assisted thoracoscopic surgery (VATS) lobectomy is associated with lower in-hospital mortality and shorter length of hospital stay versus open thoracotomy, according to a study published online Oct. 25 in the Annals of the American Thoracic Society.

Hem Desai, M.D., from the University of Arizona Health Sciences in Tucson, and colleagues used data from the U.S. Healthcare Cost and Utilization Project Nationwide Inpatient Sample database from 2009 to 2012 to compare outcomes for VATS versus open lobectomy.

Of the 27,451 patients who underwent lobectomy during the study period, 65 percent of procedures were performed by thoracotomy and 35 percent by VATS. A total of 9,393 propensity matched pairs were created. The researchers found that patients undergoing VATS lobectomy had significantly lower in-hospital mortality (1.3 versus 2.5 percent; P < 0.001) and shorter length of hospital stay (6.21 versus 8.75 days; P < 0.001). The overall rate of perioperative complications was low, with the likelihood of any perioperative morbidity lower for those undergoing VATS.

"Use of VATS for lobectomy has increased in recent years relative to thoracotomy. This trend has coincided with increased survival and shorter length of stay for VATS lobectomy compared to thoracotomy," the authors write. "Further studies are needed to identify comorbidities that identify ideal candidates for VATS lobectomy."

Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.